EP3752168A4 - Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis - Google Patents

Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis Download PDF

Info

Publication number
EP3752168A4
EP3752168A4 EP18906067.6A EP18906067A EP3752168A4 EP 3752168 A4 EP3752168 A4 EP 3752168A4 EP 18906067 A EP18906067 A EP 18906067A EP 3752168 A4 EP3752168 A4 EP 3752168A4
Authority
EP
European Patent Office
Prior art keywords
amino acid
bone mass
acid chelate
calcium absorption
treat osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18906067.6A
Other languages
German (de)
French (fr)
Other versions
EP3752168A1 (en
Inventor
Tsun-Yuan Lin
Mu-Kuei Chen
Tsang-Tse Chen
Chai-Hui Fu
Hsun-Jin Jan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yip Choi Mei
Profeat Biotechnology Co Ltd
Original Assignee
Yip Choi Mei
Profeat Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yip Choi Mei, Profeat Biotechnology Co Ltd filed Critical Yip Choi Mei
Publication of EP3752168A1 publication Critical patent/EP3752168A1/en
Publication of EP3752168A4 publication Critical patent/EP3752168A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP18906067.6A 2018-02-14 2018-02-14 Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis Withdrawn EP3752168A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2018/050067 WO2019160500A1 (en) 2018-02-14 2018-02-14 Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis

Publications (2)

Publication Number Publication Date
EP3752168A1 EP3752168A1 (en) 2020-12-23
EP3752168A4 true EP3752168A4 (en) 2021-10-13

Family

ID=67618806

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18906067.6A Withdrawn EP3752168A4 (en) 2018-02-14 2018-02-14 Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis

Country Status (2)

Country Link
EP (1) EP3752168A4 (en)
WO (1) WO2019160500A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040228950A1 (en) * 2003-05-13 2004-11-18 The Procter & Gamble Company Cereal grain kernels fortified with iron and calcium
CN101058782A (en) * 2006-04-20 2007-10-24 缪锦来 Sports beer
CN101513259B (en) * 2009-04-03 2012-01-25 重庆市生物技术研究所有限责任公司 Calcium supplementing product
CN102335266B (en) * 2011-10-22 2013-03-27 汪甬伟 Health care product for supplementing calcium
WO2014159886A1 (en) * 2013-03-14 2014-10-02 Amip, Llc Phosphorus-sparing nutritional composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07252156A (en) * 1994-03-15 1995-10-03 Meiji Seika Kaisha Ltd Medicine for prevention and therapy of osteoporosis
US20120114758A1 (en) * 2010-06-17 2012-05-10 James Elgin Rea Beverage for pregnancy & lactation
CN105145846A (en) * 2015-10-27 2015-12-16 江西美庐乳业集团有限公司 Nutritional bag for increasing bone density and improving osteoporosis
CN107509996A (en) * 2017-08-30 2017-12-26 常州市海若纺织品有限公司 A kind of bone diet nutritional powder and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040228950A1 (en) * 2003-05-13 2004-11-18 The Procter & Gamble Company Cereal grain kernels fortified with iron and calcium
CN101058782A (en) * 2006-04-20 2007-10-24 缪锦来 Sports beer
CN101513259B (en) * 2009-04-03 2012-01-25 重庆市生物技术研究所有限责任公司 Calcium supplementing product
CN102335266B (en) * 2011-10-22 2013-03-27 汪甬伟 Health care product for supplementing calcium
WO2014159886A1 (en) * 2013-03-14 2014-10-02 Amip, Llc Phosphorus-sparing nutritional composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019160500A1 *

Also Published As

Publication number Publication date
EP3752168A1 (en) 2020-12-23
WO2019160500A1 (en) 2019-08-22

Similar Documents

Publication Publication Date Title
PH12015501868A1 (en) Inhibitors of histone demethylases
EP3603661A3 (en) Rna containing composition for treatment of tumor diseases
MX2017016222A (en) Mixture for treating fertilisers containing urea.
MX2018010374A (en) Inhibitors of wdr5 protein-protein binding.
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
MX2016015434A (en) Pharmaceutical combinations for treating cancer.
EP2575884A4 (en) Uses and compositions for treatment of hidradenitis suppurativa (hs)
IL288278A (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
WO2016073989A3 (en) Osteochondroreticular stem cells for bone and cartilage regeneration
MX2014005440A (en) Nadph oxidase 4 inhibitors and use thereof.
TW201625535A (en) Inhibitors of histone demethylases
EA201890193A1 (en) COMPOSITION FOR CARE OF THE ORAL CAVITY
MX2022002635A (en) Angiopoietin-like 4 antibodies and methods of use.
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
MY191337A (en) Compositions for the treatment of hypertension and/or fibrosis
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
EP3752168A4 (en) Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis
MX2021006488A (en) Compositions for improving sexual function.
GB2530229A (en) A splint
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
MX2018002075A (en) Composition comprising tannins.
EP3768274A4 (en) A composition for use in the treatment of conditions caused by calcium deficiency
MX2015007460A (en) Diazepine derivatives useful as calcium channel blockers in the treatment of pain.
MX2016017321A (en) Combinations and methods for the treatment of neuropathic pain.
GB2587744B (en) Composition for improved bone fracture healing

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200911

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210915

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 19/10 20060101ALI20210909BHEP

Ipc: A61K 31/295 20060101ALI20210909BHEP

Ipc: A61K 31/198 20060101ALI20210909BHEP

Ipc: A61K 33/06 20060101ALI20210909BHEP

Ipc: A61K 33/26 20060101AFI20210909BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220420